| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $361.2M | $417.4M | $521.5M |
| YoY Revenue Growth % | -13.5% | -20.0% | — |
| Gross Profit | $1.8M | $10.1M | — |
| Gross Margin % | 0.5% | 2.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$25.5M | -$1.4M | -$1.1M |
| Operating Margin % | -7.0% | -0.3% | -0.2% |
| Net Income (GAAP) | -$21.4M | $371.0K | $469.0K |
| EBITDA (Normalized) | -$25.3M | -$1.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$5.4M | -$2.0M | -$13.7M |
| Capital Expenditures (CapEx) | $208.0K | $127.0K | — |
| Free Cash Flow (FCF) | -$5.6M | -$2.1M | -$13.7M |
| FCF Margin % | -1.6% | -0.5% | -2.6% |
| Return on Invested Capital (ROIC %) | -44.5% | -2.0% | — |
| Cash & Short-Term Equivalents | $5.5M | $8.7M | — |
| Total Debt (Short + Long Term) | — | $645.0K | — |
| Total Stockholders' Equity | $50.7M | $63.7M | — |